ARTIDIS Alternatives & Competitors
12 companies similar to ARTIDIS — A clinical stage company developing the first nanotechnology platform for rapid...
Companies similar to ARTIDIS
Exact Sciences
Changing the way we think about detecting and treating cancer.
Madison, United States
BioSyngen
A clinical stage biotech developing first-in-class cell therapies targeting solid and liqu...
Singapore
Berlin, Germany
NEOGAP Therapeutics AB
Science for cure.
Stockholm, Sweden
Track all ARTIDIS competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Rubik Therapeutics
Synthetic Immunity for Solid Tumors
Cambridge, United States
MedGene Therapeutics, Inc.
Better life through better science. MedGene Therapeutics, Inc. is a T cell therapy biote...
Gaithersburg, United Stat...
SAGA Diagnostics
Redefining the early detection of molecular residual disease (MRD).
Morrisville, United State...
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
Travera
Revolutionizing Cancer Therapy Guidance.
Medford, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
About ARTIDIS
ARTIDIS, founded in 2018, is a Switzerland-based clinical stage health technology company carving out a niche in the rapidly evolving field of nanotechnology for medical applications. With their pioneering approach, ARTIDIS seeks to revolutionize tissue analysis and therapy optimization by developing the first nanotech...
measuring mechanical properties of tumors, providing quantitative mechanical data, supporting research into therapy sequencing, offering same-day cancer diagnostics, enabling augmented cancer research
clinicians, oncologists, research institutions, pharmaceutical companies, healthcare providers
Nanotechnology Platform, Rapid Diagnostics, Tissue Analysis, Therapy Optimization, Solid Tumors, Chemotherapy Enhancement, Immunotherapy Enhancement, Cell Therapies, Cancer Care Precision, Nanomechanical Sensor, Tumor Aggressiveness Assessment, Nanomechanical Biomarkers, Cancer Prognosis, Atomic Force Microscopy, Personalized Therapy
B2B, DaaS, Platform
Service Fee, Data Monetization, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches ARTIDIS and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at ARTIDIS on 21 May 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
